Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.
Market Volatility Drops Further Following Upbeat Payrolls Report
US stocks closed mixed on Friday as investors digested better-than-expected data on nonfarm payrolls.